Pomerantz Law Firm Investigates Potential Securities Fraud at Concentrix Corporation (CNXC)
Pomerantz LLP has launched an investigation into Concentrix Corporation (NASDAQ: CNXC) following significant financial setbacks and downward revisions to its guidance. The probe seeks to determine if the company or its executives engaged in securities fraud or unlawful business practices regarding recent disclosures. The scrutiny follows two major negative developments: a June 2026 announcement where the company lowered revenue and earnings forecasts due to offshoring trends, causing an 11.18% stock price drop; and a September 2026 disclosure of a $1.05 billion noncash goodwill impairment. Combined with previous charges, these impairments have totaled approximately $2.57 billion.
Tickers: $CNXC
Topics: class action lawsuit goodwill impairment revenue guidance reduction securities fraud investigation